目的：观察止眩汤加减治疗脑卒中后眩晕患者的临床疗效。方法：将60 例脑卒中后眩晕患者按随机数字表法分为治疗组与对照组各30 例。2 组均进行基础治疗，对照组外加盐酸倍他司汀片治疗，治疗组在对照组基础上给予止眩汤加减治疗。比较2 组治疗后临床疗效及治疗前后眩晕障碍量表（DHI） 评分、WOLF 运动功能量表（WMFT） 评分、Berg 平衡量表（BBS）评分、功能独立测量量表（FIM） 评分。结果：治疗组临床总有效率93.33%，显著高于对照组70.00%（P＜0.05）。与同组治疗前比较，治疗后2 组DHI 各项评分及总分均降低（P＜0.05），WMFT、BBS、FIM 评分均升高（P＜0.05）；与对照组治疗后比较，治疗组治疗后DHI 各项评分及总分均较低（P＜0.05），WMFT、BBS、FIM 评分均较高（P＜0.05）。结论：止眩汤加减联合盐酸倍他司汀片可有效提高脑卒中后眩晕患者临床疗效，改善其眩晕症状，提高其运动功能、平衡能力及功能独立性。
Abstract：Objective：To observe the clinical effect of modified Zhixuan tang for vertigo after stroke. Methods：A total of 60 cases of patients with vertigo after stroke were divided into the treatment group and the control group according to the random number table method，with 30 cases in each group. Both groups were given basic treatment；the control group was additionally treated with betahistine hydrochloride tablets， and the treatment group was additionally treated with modified Zhixuan tang based on the treatment of the control group. The scores of Dizziness Handicap Inventory(DHI)，WOLF Motor Function Test(WMFT)， Berg Balance Scale(BBS) and Functional independent measurement scale(FIM) before and after treatment as well as the clinical effects after treatment in the two groups were compared. Results：The total effective rate was 93.33% in the treatment group，significantly higher than that of 70.00% in the control group(P＜0.05). After treatment， the all grades and total scores of DHI in the two groups were decreased(P＜0.05)，and the scores of WMFT，BBS and FIM were increased when compared with those before treatment(P＜0.05)；and the all grades and total scores of DHI were lower than those in the control group(P＜0.05)，and the scores of WMFT，BBS and FIM in the treatment group were higher (P＜ 0.05). Conclusion： Modified Zhixuan tang combined with betahistine hydrochloride tablets can effectively improve clinical effect of patients with vertigo after stroke， and enhance their symptom of vertigo， motor function， balance ability and functional independence.